News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nevro Corp Announces Issuance of Additional Key U.S. Patents for Innovative Chronic Pain Treatment


1/24/2013 9:50:36 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--Nevro Corp., a medical device company focused on improving the lives of patients suffering from debilitating chronic pain, announced today the issuance of four additional key patents related to the company’s Senza® system and HF10™ SCS therapy.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES